KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Total Liabilities (2016 - 2025)

Gilead Sciences' Total Liabilities history spans 17 years, with the latest figure at $36.3 billion for Q4 2025.

  • For Q4 2025, Total Liabilities fell 8.43% year-over-year to $36.3 billion; the TTM value through Dec 2025 reached $36.3 billion, down 8.43%, while the annual FY2025 figure was $36.3 billion, 8.43% down from the prior year.
  • Total Liabilities reached $36.3 billion in Q4 2025 per GILD's latest filing, down from $37.1 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $48.5 billion in Q1 2021 to a low of $35.4 billion in Q2 2024.
  • Average Total Liabilities over 5 years is $40.9 billion, with a median of $40.5 billion recorded in 2023.
  • Peak YoY movement for Total Liabilities: grew 29.19% in 2021, then fell 14.21% in 2024.
  • A 5-year view of Total Liabilities shows it stood at $46.9 billion in 2021, then dropped by 10.51% to $42.0 billion in 2022, then dropped by 6.16% to $39.4 billion in 2023, then grew by 0.73% to $39.7 billion in 2024, then fell by 8.43% to $36.3 billion in 2025.
  • Per Business Quant, the three most recent readings for GILD's Total Liabilities are $36.3 billion (Q4 2025), $37.1 billion (Q3 2025), and $36.1 billion (Q2 2025).